These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 14, 2015
ESSA Pharma Inc. ("ESSA" or the "Company") (TSX: EPI, NASDAQ: EPIX) today reported financial results for the year ended September 30, 2015. Amounts, unless specified otherwise, are expressed in...
-
Nov 24, 2015
ESSA Pharma Inc. ("ESSA" or the "Company") (TSX: EPI; NASDAQ: EPIX) announced today that the first patient has been enrolled in ESSA's Phase 1/2 clinical study of EPI-506 as a treatment for...
-
Nov 5, 2015
ESSA Pharma Inc. ("ESSA" or the "Company") (TSX: EPI; NASDAQ: EPIX) announced today that the Health Protection Branch ("HPB") of Health Canada has issued a 'no objection letter' for the Clinical...
-
Sep 23, 2015
ESSA Pharma Inc. ("ESSA" or the "Company") (TSX: EPI; NASDAQ: EPIX) announced today that the U.S. Food and Drug Administration ("FDA") has approved its Investigational New Drug ("IND") application...
-
Aug 17, 2015
ESSA Pharma Inc. ("ESSA" or the "Company") (TSX: EPI, NASDAQ: EPIX) today reported financial results for the third quarter and three months ended June 30, 2015. Amounts, unless specified...
-
Jul 28, 2015
ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX) is pleased to announce that it has received final approval for its common shares to be listed and commence trading on the Toronto Stock...
-
Jul 2, 2015
ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI) announced today that its common shares have been approved for listing and trading on the NASDAQ Capital Market ("NASDAQ") under the symbol...
-
Jun 24, 2015
ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI) announced today that it has appointed Dr. David Parkinson to its board of directors. Dr. Parkinson's appointment as an independent director...
-
May 28, 2015
ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI) today reported financial results for the second quarter and three and six months ended March 31, 2015. Amounts, unless specified otherwise,...
-
May 4, 2015
ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI) announced today that it has received notification from the Food and Drug Administration ("FDA" or the "Agency") in the US that the Company's...
